MedPath

The IBD-FITT Study - Moderate-intensity Exercise for IBD Patients With Moderate Disease Activity

Not Applicable
Completed
Conditions
Inflammatory Bowel Diseases
Interventions
Behavioral: Lifestyle - online lesson intervention
Behavioral: Exercise intervention
Registration Number
NCT04816812
Lead Sponsor
University of Southern Denmark
Brief Summary

The investigators aim to investigate whether exercise therapy during 12 weeks including a lesson on general healthy lifestyle in adult patients with a moderately active disease is more effective, compared to control patients only receiving a lesson on general healthy lifestyle recommendations. The three main categories of outcomes are 1) health-related quality of life, 2) general health status of the patients 3) explorative outcomes. The primary outcome is health-related quality of life, the secondary outcome is general health status measured by waist circumference, disease activity scores, blood pressure, and blood lipids, and the third outcome are explorative outcomes (none-disease specific quality of life scores, biomarkers of C-reactive protein, fecal calprotectin and immunology markers including interleukins).

Detailed Description

The investigators will apply a superior trial design in this randomized clinical trial with two arms, intervention and comparison. In both the intervention and comparison arm, the patients will receive the proper and usual medical treatment decided by their responsible physician and changes in the medical treatment is allowed at all times.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
44
Inclusion Criteria
  • Patients with moderately active Crohn's disease or ulcerative colitis are defined by fulfilling all the following five criteria:

    1. Well-characterized Crohn's disease or ulcerative colitis (physician assessment) i. Fulfilling standard clinical, endoscopic, radiologic, and histological criteria

    2. A minimum of one-year disease duration from the time of diagnosis of Crohn's disease or ulcerative colitis to inclusion into the trial

    3. Any of the following pharmacological treatments in a period of three months prior to inclusion:

      i. Usage of 5-Aminosalicylic acid (5-ASA) ii. Usage of corticosteroids iii. Immunomodulators usage: Azathioprine (AZA), 6-mercaptopurine (6-MP), Methotrexate (MTX) iv. Biologics usage: Anti-TNFα (Infliximab, Adalimumab, Golimumab), Ustekinumab or Anti-integrin (Vedolizumab)

    4. Disease activity defined by clinical disease score:

      i. Harvey Bradshaw Index (HBI) 27 > 5 ii. Simple Clinical Colitis Activity Index (SCCAI) 29 > 5

    5. Marker for gastrointestinal inflammation:

      i. Fecal calprotectin (FC) > 200 mg/g

Exclusion Criteria
    1. A language barrier that prohibits the exercise instructors/supervisors to give sufficient or safe instructions during the intervention or at the general health lesson.

    2. Known heart condition that prevents them to actively participate safely in the exercise intervention.

    3. Known pregnancy or planned pregnancy. 4. Disabling musculoskeletal injuries that prevent them to actively participate in the exercise intervention.

    4. Severe disease activity manifested clinically and with the need for urgent change in treatment evaluated by the responsible physician.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ComparisonLifestyle - online lesson interventionComparison
ExerciseLifestyle - online lesson interventionIn the intervention arm, a 12-week aerobic exercise program tailored to the individual patients by physiotherapists using the principles of Frequency, Intensity, Time, and, Type (FITT) aiming to increase or maintain the physical activity level to a weekly moderate activity level.
ExerciseExercise interventionIn the intervention arm, a 12-week aerobic exercise program tailored to the individual patients by physiotherapists using the principles of Frequency, Intensity, Time, and, Type (FITT) aiming to increase or maintain the physical activity level to a weekly moderate activity level.
Primary Outcome Measures
NameTimeMethod
Inflammatory Bowel Disease Questionnaire (IBDQ)12 weeks

Health-related quality of life

Secondary Outcome Measures
NameTimeMethod
General health - blood pressure12 weeks

Blood pressure

General health - Waist circumference12 weeks

Waist circumference

General health - Lipid12 weeks

Lipid status:

i. Low-density lipoprotein (LDL) ii. High-density lipoprotein (HDL) iii. Triglycerides iv. Total cholesterol v. Hemoglobin A (Hbac1)

General health - Clinical disease activity12 weeks

Harvey Bradshaw Index (Crohn's disease) Simple Clinical Colitis Activity Index (Ulcerative colitis)

Trial Locations

Locations (2)

Hospital of Southwest Jutland

🇩🇰

Esbjerg, Denmark

Odense University Hospital

🇩🇰

Odense, Denmark

© Copyright 2025. All Rights Reserved by MedPath